Records 1-4 (of 4 Records) |
Query Trace: Neuromyelitis optica spectrum disorder[original query] |
---|
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore. Yeo Tianrong, et al. Journal of neurology 2023 0 0. 1-9 |
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach. ApÓstolos-Pereira Samira Luisa, et al. Arquivos de neuro-psiquiatria 2020 0 0. (7) 430-439 |
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Brownlee Wallace, et al. Neurology 2020 0 0. (22) 949-952 |
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis. Salama Sara, et al. Multiple sclerosis and related disorders 2020 0 0. 102259 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: